WCN24-2097 Real life lupus nephritis: long-term prognostic value of proteinuria outside of a trial

WCN24-2097 Real life lupus nephritis: long-term prognostic value of proteinuria outside of a trial

Saved in:

Bibliographic Details
Main Authors:	Nicolás Contrera Rolón, Alfredo Vargas Caselles, Marina Scolnik, Nicolás Alvarado, Carlos Federico Varela, Gustavo Greloni, Griselda Bratti, Enrique Roberto Soriano, Javier Eduardo Rosa, María Cora Giordani
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924004637
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN24-2435 CLINICAL CHARACTERISTICS OF PATIENTS WITH C3 GLOMERULOPATHY AND IDIOPATHIC MEMBRANOPROLIFERATIVE IMMUNE COMPLEX GLOMERULONEPHRITIS IN A HOSPITAL IN ARGENTINA
by: Lucas Ramos, et al.
Published: (2024-04-01)

Serum levels of adiponectin and leptin as biomarkers of proteinuria in lupus nephritis.
by: Valeria Diaz-Rizo, et al.
Published: (2017-01-01)

WCN24-2673 COMPLEMENT LEVELS AND PROTEINURIA IN LUPUS NEPHRITIS CORRELATIONS AND TREATMENT RESPONSE
by: Maria Izabel de Holanda, et al.
Published: (2024-04-01)

Renal pathology-related factors in non-nephrotic-range proteinuria of lupus nephritis patients
by: LIU Ting-ting, et al.
Published: (2019-01-01)

WCN25-4520 THE RELATIONSHIP BETWEEN PROTEINURIA, HEMATURIA, AND HISTOPATHOLOGICAL CHANGES IN LUPUS NEPHRITIS
by: Henrique Borges, et al.
Published: (2025-02-01)

WCN24-2535 Epidemiology of ADPKD in a medical center in Argentina
by: Hernan Dario Huertas Estrada, et al.
Published: (2024-04-01)

MO-2097 inhibits EMT and angiogenesis in colorectal cancer by targeting RAF/MEK/ERK signaling
by: Sumin Kim, et al.
Published: (2025-07-01)

WCN25-2084 EVALUATION OF TUBULOGLOMERULAR OUTCOME BY MEASURING PROTEINURIA AND URINARY NGAL AFTER INDUCTION BY MMF IN CLASS III/IV LUPUS NEPHRITIS
by: Md. Aminul Haq, et al.
Published: (2025-02-01)

WCN24-1455 NOT EVERYTHING IN LUPUS IS LUPUS NEPHRITIS
by: Enrique Fleuvier Morales López, et al.
Published: (2024-04-01)

The Evolution of Crescents in Lupus Nephritis
by: Ana Malvar, et al.
Published: (2025-05-01)

Gender Differences in the Pathogenesis and Outcome of Lupus and of Lupus Nephritis
by: Julie Schwartzman-Morris, et al.
Published: (2012-01-01)

Prospects for the use of belimumab in lupus nephritis
by: N. L. Kozlovskaya, et al.
Published: (2021-08-01)

Evaluation of Treatment Response in Lupus Nephritis
by: Anca BOBIRCA, et al.
Published: (2021-12-01)

Recent advances in the treatment of lupus nephritis
by: Wan-xing Li, et al.
Published: (2022-08-01)

USE OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS
by: Anna Vasilyevna Torgashina, et al.
Published: (2010-08-01)

Clinical application of belimumab in lupus nephritis
by: Zhou Han, et al.
Published: (2022-10-01)

Immune characterization of lupus nephritis patients undergoing dialysisKey messages
by: Quentin Simon, et al.
Published: (2025-06-01)

The impacts of gender differences on systemic lupus erythematosus and lupus nephritis
by: LI Chun-hong, et al.
Published: (2019-01-01)

Immune Checkpoint Therapy–Induced Lupus Nephritis
by: Imran Humza Hanif, et al.
Published: (2024-05-01)

Lupus nephritis: What new is in morphological diagnosis?
by: S G Radenska-Lopovok
Published: (2008-08-01)

Lupus Nephritis: 10 questions to think about
by: Enrique Morales, et al.
Published: (2025-02-01)

Chemokines and Chemokine Receptors in the Development of Lupus Nephritis
by: Xiaofeng Liao, et al.
Published: (2016-01-01)

Lupus nephritis and thrombotic microangiopathy: A review
by: Larisa A. Bobrova, et al.
Published: (2024-01-01)

Prediction of prognosis and renal outcome in lupus nephritis
by: Farah Tamirou, et al.
Published: (2020-10-01)

Disseminated Strongyloidiasis in a Patient With Lupus Nephritis
by: Muhammad Abu-Rmaileh, et al.
Published: (2023-09-01)

MicroRNAs Implicated in the Immunopathogenesis of Lupus Nephritis
by: Cristen B. Chafin, et al.
Published: (2013-01-01)

Renal biopsy in lupus nephritis: To do or not to do?
by: Manish Rathi, et al.
Published: (2017-01-01)

Clinical significance of urine hepcidin in lupus nephritis
by: TANG Dai-rong, et al.
Published: (2017-01-01)

B cells and treatment progression in lupus nephritis
by: ZHANG Yue-qi, et al.
Published: (2019-01-01)

Research advances of the role of T lymphocytes in lupus nephritis
by: Zhang Ling-ge, et al.
Published: (2022-03-01)

Ras-MAPK pathway in patients with lupus nephritis
by: Dandan Liang, et al.
Published: (2025-03-01)

Lupus nephritis as a specific clinical and immunological phenotype of systemic lupus erythematosus
by: E. A. Aseeva, et al.
Published: (2022-12-01)

Lupus Nephritis in a Patient with Sickle Cell Disease
by: Vinay Minocha, et al.
Published: (2013-01-01)

Soluble Fas and the −670 Polymorphism of Fas in Lupus Nephritis
by: Juan José Bollain-y-Goytia, et al.
Published: (2014-01-01)

Correlation between dyslipidemia and disease activity of lupus nephritis
by: Hu Hong-tu, et al.
Published: (2021-01-01)

FDA approves belimumab for treatment of children with lupus nephritis
by: article Editorial
Published: (2022-10-01)

TNIP1/ABIN1 and lupus nephritis: review
by: Makayla P Brady, et al.
Published: (2020-10-01)

Cyclophosphamide and mycophenolate mofetil as induction therapy in lupus nephritis
by: Božić-Majstorović Ljubinka, et al.
Published: (2024-01-01)

Determination of nutrition index and correlation with activity of lupus nephritis
by: Rabrenović Violeta, et al.
Published: (2024-01-01)

Bioinformatics analysis of gene expression microarray in lupus nephritis
by: JIANG Qiu-zhu, et al.
Published: (2020-01-01)